Tissue factor is involved in retinoblastoma cell proliferation via both the Akt and extracellular signal-regulated kinase pathways

Oncology Reports

Volumn 26, Issue 3, 2011, Pages 665-670

  Lee, Byung Joo ^a   Kim, Jeong Hun ^a,b   Woo, Seung Hoon ^c   Kim, Jin Hyoung ^a   Kim, Dong Hun ^d   Yu, Young Suk ^a,b  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University   (South Korea)

^c Gyeongsang National University   (South Korea)

^d Soonchunhyang University   (South Korea)

Author keywords

Akt; Extracellular signal regulated kinase; Proliferation; Retinoblastoma; Tissue factor; Tissue factor pathway inhibitor

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; TISSUE FACTOR PATHWAY INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CELL LEVEL; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; MITOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RETINOBLASTOMA; SIGNAL TRANSDUCTION;

ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; FIBROBLAST GROWTH FACTOR 2; HUMANS; KI-67 ANTIGEN; LIPOPROTEINS; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED BALB C; MICE, NUDE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEOPLASM TRANSPLANTATION; PROTO-ONCOGENE PROTEINS C-AKT; RETINAL NEOPLASMS; RETINOBLASTOMA; THROMBOPLASTIN; TRANSPLANTATION, HETEROLOGOUS;

EID: 79959926940     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1314     Document Type: Article

References (34)

1. Marback EF, Arias VE, Paranhos A Jr, Soares FA, Murphree AL and Erwenne CM: Tumour angiogenesis as a prognostic factor for disease dissemination in retinoblastoma. Br J Ophthalmol 87: 1224-1228, 2003. (Pubitemid 37193910)
2. Chong EM, Coffee RE, Chintagumpala M, Hurwitz RL, Hurwitz MY and Chevez-Barrios P: Extensively necrotic retinoblastoma is associated with high-risk prognostic factors. Arch Pathol Lab Med 130: 1669-1672, 2006. (Pubitemid 44683795)
3. Bick RL: Cancer-associated thrombosis. N Engl J Med 349: 109-111, 2003.
4. Lee AY: Thrombosis and cancer: the role of screening for occult cancer and recognizing the underlying biological mechanisms. Hematology Am Soc Hematol Educ Program 2006: 438-443, 2006.
5. Bromberg ME, Konigsberg WH, Madison JF, Pawashe A and Garen A: Tissue factor promotes melanoma metastasis by a pathway independent of blood coagulation. Proc Natl Acad Sci USA 92: 8205-8209, 1995.
6. Contrino J, Hair G, Kreutzer DL and Rickles FR: In situ detection of tissue factor in vascular endothelial cells: correlation with the malignant phenotype of human breast disease. Nat Med 2: 209-215, 1996.
7. Seto S, Onodera H, Kaido T, et al: Tissue factor expression in human colorectal carcinoma: correlation with hepatic metastasis and impact on prognosis. Cancer 88: 295-301, 2000. (Pubitemid 30051812)
8. Khorana AA, Ahrendt SA, Ryan CK, et al: Tissue factor expression, angiogenesis, and thrombosis in pancreatic cancer. Clin Cancer Res 13: 2870-2875, 2007. (Pubitemid 46849560)
9. Abdulkadir SA, Carvalhal GF, Kaleem Z, et al: Tissue factor expression and angiogenesis in human prostate carcinoma. Hum Pathol 31: 443-447, 2000. (Pubitemid 30262866)
10. Poon RT, Lau CP, Ho JW, Yu WC, Fan ST and Wong J: Tissue factor expression correlates with tumor angiogenesis and invasiveness in human hepatocellular carcinoma. Clin Cancer Res 9: 5339-5345, 2003. (Pubitemid 37413589)
11. Ogiichi T, Hirashima Y, Nakamura S, Endo S, Kurimoto M and Takaku A: Tissue factor and cancer procoagulant expressed by glioma cells participate in their thrombin-mediated proliferation. J Neurooncol 46: 1-9, 2000. (Pubitemid 30352607)
12. Cirillo P, Cali G, Golino P, et al: Tissue factor binding of activated factor VII triggers smooth muscle cell proliferation via extracellular signal-regulated kinase activation. Circulation 109: 2911-2916, 2004. (Pubitemid 38780307)
13. Fan L, Yotov WV, Zhu T, et al: Tissue factor enhances protease-activated receptor-2-mediated factor Vila cell proliferative properties. J Thromb Haemost 3: 1056-1063, 2005. (Pubitemid 41632839)
14. Gospodarowicz D, Brown KD, Birdwell CR and Zetter BR: Control of proliferation of human vascular endothelial cells. Characterization of the response of human umbilical vein endothelial cells to fibroblast growth factor, epidermal growth factor, and thrombin. J Cell Biol 77: 774-788, 1978.
15. Carney DH, Stiernberg J and Fenton JW II: Initiation of proliferative events by human alpha-thrombin requires both receptor binding and enzymic activity. J Cell Biochem 26: 181-195, 1984. (Pubitemid 15184554)
16. Chen LB and Buchanan JM: Mitogenic activity of blood components. I. Thrombin and prothrombin. Proc Natl Acad Sci USA 72: 131-135, 1975.
17. Versteeg HH, Schaffner F, Kerver M, et al: Inhibition of tissue factor signaling suppresses tumor growth. Blood 111: 190-199, 2008.
18. Girard TJ, Warren LA, Novotny WF, et al: Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor. Nature 338: 518-520, 1989. (Pubitemid 19107996)
19. Hembrough TA, Ruiz JF, Papathanassiu AE, Green SJ and Strickland DK: T inhibits endo-thelial cell proliferation via association with the very low density lipoprotein receptor. J Biol Chem 276: 12241-12248, 2001.
20. Hembrough TA, Ruiz JF, Swerdlow BM, et al: Identification and characterization of a very low density lipoprotein receptor-binding peptide from tissue factor pathway inhibitor that has antitumor and antiangiogenic activity. Blood 103: 3374-3380, 2004. (Pubitemid 38525667)
21. Kamikubo Y, Nakahara Y, Takemoto S, Hamuro T, Miyamoto S and Funatsu A: Human recombinant tissue-factor pathway inhibitor prevents the proliferation of cultured human neonatal aortic smooth muscle cells. FEBS Lett 407: 116-120, 1997. (Pubitemid 27174498)
22. Reid TW, Albert DM, Rabson AS, et al: Characteristics of an established cell line of retinoblastoma. J Natl Cancer Inst 53: 347-360, 1974.
23. Kim JH, Yu YS, Kim DH, Kim CJ and Kim KW: Establishment and characterization of a novel, spontaneously immortalized retinoblastoma cell line with adherent growth. Int J Oncol 31: 585-592, 2007.
24. Cebulla CM, Jockovich ME, Pina Y, et al: Basic fibroblast growth factor impact on retinoblastoma progression and survival. Invest Ophthalmol Vis Sci 49: 5215-5221, 2008.
25. Schweigerer L, Neufeld G and Gospodarowicz D: Basic fibroblast growth factor is present in cultured human retinoblastoma cells. Invest Ophthalmol Vis Sci 28: 1838-1843, 1987.
26. Nitori N, Ino Y, Nakanishi Y, et al: Prognostic significance of tissue factor in pancreatic ductal adenocarcinoma. Clin Cancer Res 11: 2531-2539, 2005. (Pubitemid 40569450)
27. Hamada K, Kuratsu J, Saitoh Y, Takeshima H, Nishi T and Ushio Y: Expression of tissue factor correlates with grade of malignancy in human glioma. Cancer 77: 1877-1883, 1996.
28. Pendurthi UR, Williams JT and Rao LV: Acidic and basic fibroblast growth factors suppress transcriptional activation of tissue factor and other inflammatory genes in endothelial cells. Arterioscler Thromb Vasc Biol 17: 940-946, 1997. (Pubitemid 27209273)
29. Darmoul D, Oratio V, Devaud H and Laburthe M: Protease-activated receptor 2 in colon cancer: trypsin-induced MAPK phosphorylation and cell proliferation are mediated by epidermal growth factor receptor transactivation. J Biol Chem 279: 20927-20934, 2004.
30. Sulpice E, Bryckaert M, Lacour J, Confreres JO and Tobelem G: Platelet factor 4 inhibits FGF2-induced endothelial cell proliferation via the extracellular signal-regulated kinase pathway but not by the phosphatidylinositol 3-kinase pathway. Blood 100: 3087-3094, 2002. (Pubitemid 35217053)
31. Ishibe T, Nakayama T, Okamoto T, et al: Disruption of fibroblast growth factor signal pathway inhibits the growth of synovial sarcomas: potential application of signal inhibitors to molecular target therapy. Clin Cancer Res 11: 2702-2712, 2005. (Pubitemid 40569472)
32. Kim JH, Yu YS, Kim DH, Kim YK and Kim KW: Comparative genomic hybridization analysis of newly established retinoblastoma cell lines of adherent growth compared with Y79 of nonadherent growth. J Pediatr Hematol Oncol 30: 571-574, 2008.
33. Rauch BH, Millette E, Kenagy RD, Daum G and Clowes AW: Thrombin- and factor Xa-induced DNA synthesis is mediated by transactivation of fibroblast growth factor receptor-1 in human vascular smooth muscle cells. Circ Res 94: 340-345, 2004. (Pubitemid 38240725)
34. Abe K, Aslam A, Walls AF, Sato T and Inoue H: Up-regulation of protease-activated receptor-2 by bFGF in cultured human synovial fibroblasts. Life Sci 79: 898-904, 2006.